Karen McCarthy serves as the Executive Director of Early Development at PPD and has more than 30 years of experience in drug development. Her clinical development experience has included oversight of the development of viral and bacterial vaccine development programs from concept to license submission and involved genetically modified, live-attenuated, inactivated, conjugate, recombinant, sub-unit, vector-mediated and toxoid vaccines across a range of infectious disease indications, including seasonal respiratory diseases.
.svg)
